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Pulmonary involvement due to Wegener’s granulomatosis (WG) can present radiologically either as diffuse 
infiltrates or as nodular and linear opacities. Clinical experience suggests that these radiological patterns are 
associated with different bronchoalveolar lavage (BAL) cell profiles, but this has not been examined formally. 
We compared the BAL cell profile in eight WC patients with diffuse infiltrates on chest X-ray, indicative of highly 
active pneumonitis, with corresponding findings in 37 patients with nodular, linear and focal low-attenuation 
infiltrates on high-resolution computed tomography (HRCT) which reflected low-grade, mainly interstitial disease. 
A control group was composed of 11 patients with pulmonary sarcoidosis. 
Diffuse infiltrates occurred in association with high systemic disease activity and featured a neutrophilic BAL 
profile in the presence of generally normal BAL lymphocytes. HRCT findings suggestive mainly of interstitial disease 
were associated with either a lymphocytic BAL cell profile or a normal cell pattern. Patients with a lymphocytic cell 
profile generally had a preferential elevation of CD4+ cells in the BAL in the presence of a normal CD4/CD8 ratio 
in the blood. This was a common feature of WG and pulmonary sarcoidosis. 
In conclusion, highly active pneumonitis and pulmonary disease of low or moderate activity in WG are associated 
with disparate BAL cell profiles. It remains to be examined whether the preferential elevation of CD4+ cells in the 
latter condition reflects a common pathogenetic role of this subset of cells in WC and pulmonary sarcoidosis. 
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Wegener’s granulomatosis (WG) is an inflammatory multi- 
organ disease of unknown aetiology which almost always 
affects the respiratory tract (1). Roentgenologically, the two 
most common disease patterns at the lung are either 
ill-defined infiltrates or solitary or multiple, cavitating 
or non-cavitating nodules (2,3). The diffuse infiltrates 
generally occur in association with high systemic disease 
activity. The underlying histopathology is either acute 
parenchymal damage with airspace consolidation and infil- 
tration mainly by neutrophils, or an infiltrate resulting from 
diffuse alveolar bleeding (45). A more chronic type of 
inflammatory infiltration usually underlies the nodular 
roentgenological infiltrates (4,5). The prototype lesion is 
the necrotizing granuloma of WG, the prevailing cellular 
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elements of which are histiocytes, lymphocytes and 
multinucleate giant cells (4-6). 
This latter category of roentgenological morphology was 
recently augmented by high-resolution computed tomogra- 
phy (HRCT) findings (7-9). This disclosed a range of less 
obtrusive parenchymal abnormalities consisting of small 
nodules, septal and non-septal lines and focal low- 
attenuation opacities, many of which had eluded detection 
by conventional chest X-ray (CXR) (9). It is our experience 
that a major proportion of these changes recedes under 
immunosuppressive treatment, marking them as active 
inflammatory lesions. Bronchoalveolar lavage @AL) 
revealed that these changes are commonly associated with a 
lymphocytic cell profile, whereas previous studies of 
patients with highly active lung disease due to WG showed 
mainly neutrophilic cell profiles (2,10,11). 
To substantiate the impression that lung disease due to 
WG is associated with disparate BAL cell patterns depend- 
ing on disease activity, we recruited two patient groups on 
the basis of radiological features, A group with high 
pulmonary disease activity was recruited on the basis of 
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ill-defined infiltrates in the CXR in the presence of high 
systemic disease activity. A second group was recruited on 
the basis of a normal CXR but nodular or linear infiltrates 
on HRCT suggestive of moderately active, mainly inter- 
stitial lung disease. The BAL cell pattern in these two 
groups was determined morphologically and, in the event of 
elevated lymphocytes, by immunotyping for CD3’ T cells, 
CD4’ helper/inducer cells and CD8” suppressor/cytotoxic 
cells. 
Patients and Methods 
PATIENTS 
The study included 45 consecutive patients (20 women, 25 
men; median age 57.0 years, 95% confidence interval 49-64 
years) with active WG. WG was diagnosed according to the 
1990 American College of Rheumatology criteria (12) and 
the 1994 Chapel-Hill definition (13). The site of histological 
confirmation was the upper respiratory tract in 28 patients, 
the lung in three, the kidney in two, the skin in one and 
skeletal muscle in one. The patients received a comprehen- 
sive staging examination, including ophthalmological, 
otorhinolaryngological and neurological referral, CXR, 
lung function testing, bronchoscopy and BAL. The range of 
organ system involvement and the extent of disease was 
scored using the disease extent index (DEI) (14). Anti- 
neutrophil cytoplasmic antibodies (ANCA) testing by a 
standard immunofluorescence test, followed by testing with 
mono-specific ELISA, resulted in a PR3-ANCA in 39 
patients, cANCA of undetermined specificity in one and 
MPO-ANCA in two (15). 
The high disease activity group consisted of eight patients 
presenting with widespread, ill-defined infiltrates in the 
CXR in the presence of high systemic disease activity. 
Excluded were patients with microbiological evidence of 
infection and patients with clinical or bronchoscopic evi- 
dence of alveolar bleeding. Four of the eight patients were 
examined at initial presentation with generalized disease 
and were untreated. Four patients were examined during a 
relapse and two of these were on cyclophosphamide. The 
low disease activity group consisted of 37 patients with 
active, progressive WG who had pulmonary symptoms 
(cough, dyspnoea), abnormal lung function tests (vital 
capacity or CO diffusion capacity below 80% of predicted 
values) or a history of lung disease due to WG but a normal 
CXR. These patients were subjected to HRCT and all of 
them had abnormal parenchymal HRCT findings, which 
were comprised of septal or non-septal lines, small nodules 
or low-attenuation opacities. Thirteen of these patients 
were examined at initial presentation and 24 patients during 
follow-up. Eighteen patients were untreated, seven were on 
low-dose prednisolone, six were on cyclophosphamide and 
six were on low-dose methotrexate. 
For comparison, the BAL cell profile and T-cell subsets 
in BAL and blood were examined in five women and six 
men with a median age of 35 years (range 2841 years) with 
pulmonary sarcoidosis. The diagnosis was based on the 
criteria of Yamamoto and Sharma (16) and all patients had 
highly active disease associated with systemic manifesta- 
tions. The latter were arthralgia or arthritis in 11 patients 
and erythema nodosum in five. 
HRCT, PULMONARY FUNCTION TESTING 
Pulmonary HRCT was performed with a Somatom Plus-S 
device (Siemens, Erlangen, Germany). Thin-section radio- 
graphs (l-mm section thickness) were taken at maximum 
inspiration from the apex to the base of the lungs by a table 
feed of 10 mm. Scans were reconstructed by means of a high 
spatial frequency reconstruction algorithm and images 
were documented at window settings appropriate for lung 
parenchyma (20001-450). Pulmonary function was 
measured using a MasterLab unit (Jaeger, Wuerzburg, 
Germany) according to the recommendations of the 
American Thoracic Society (17). Values for the CO diffu- 
sion capacity were corrected for haemoglobin and alveolar 
volume as measured by the helium dilution technique (18). 
BRONCHOSCOPY AND TRANSBRONCHIAL 
BIOPSY 
Fibre-optic bronchoscopy was performed after local 
anaesthesia with lidocaine and premeditation with atropine 
and a morphine antitussant. BAL was directed at lung areas 
showing abnormal CXR or HRCT findings. The broncho- 
scope was wedged into a segmental bronchus and 10 
fractions of 20-ml sterile saline 0.9% were instilled and 
aspirated. The recovered material was examined for con- 
ventional bacterial pathogens, acid-fast bacteria, Legionella 
spp, Chlamyclia spp, Mycoplasma spp and Pneumocystis 
cavinii. Any infected material was omitted from further 
study. Transbronchial biopsy (TBB) was also directed at 
radiologically abnormal lung areas. Tissue specimens were 
transferred into buffered formalin and embedded in paraf- 
fin. Sections were stained with haematoxylin and eosin and 
evaluated for inflammatory cells by morphological criteria. 
BAL CELL ANALYSIS 
The lavage material was centrifuged and the cell pellet was 
resuspended in RPM1 1640 medium (Gibco, Eggenstein, 
Germany) to a density of lo6 cells ml-‘. Cytospin prep- 
arations were prepared with a Shandon II cytocentrifuge 
(Shandon Products, Cheshire, U.K.) and stained according 
to May-Giemsa-Gruenwald. The cell differential was 
assessed by counting 300 cells. Normal reference values in 
this laboratory are < 15% for lymphocytes, I 5% for 
neutrophils and 5 1% for eosinophils. In the event of an 
elevated lymphocyte count, BAL and blood lymphocytes 
were immunophenotyped for T cells and T-cell subsets. 
BAL cells were suspended in RPM1 1640 containing 0.01% 
human serum albumin (Sigma, Munich, Germany) and 
incubated for 30 min with fluorescence-conjugated anti- 
CD3, anti-CD4, and anti-CD8 (Coulter, Krefeld and 
Becton Dickinson, Heidelberg, Germany). After a final 
wash, cells were measured in a Coulter EPICS II flow 
cytometer. Blood samples were subjected to lysis of 
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TABLE 1. Characteristics of patients with pneumonitis due to Wegener’s granulomatosis (high pulmonary disease activit 
group) 
Patient 
Current organ 
involvement 
Disease ESR CRP 
extent index ANCA-titre (mm h - ‘) (mg dl - ‘) Chest X-ray 
W.E. female, 71 years 
H.D., male, 39 years 
K.R., female, 44 years 
R.L., male, 58 years 
S.D., male, 40 years 
F.H., male, 55 years 
P.H., female, 65 years 
P.W.; male, 61 years 
ENT, lung, kidney, 
heart, B symptoms 
ENT, lung, kidney, 
neuropathy, arthritis, 
B symptoms 
ENT, eye, lung, 
arthritis, neuropathy, 
B symptoms 
ENT, lung, 
B symptoms 
Lung, kidney, 
arthritis, B symptoms 
ENT, lung, kidney, 
skin, central and 
peripheral nervous 
system, arthritis, 
B symptoms 
Lung, kidney, 
B symptoms 
Lung, eye, arthritis, 
skin, gastrointestinal 
tract, B symptoms 
9 12048 1000 
11 1:64 120 
11 I:128 
5 1:32 135 39.4 Bilateral infiltrates 
7 1:256 70 16.7 Bilateral infiltrates 
15 1:64 90 5‘9 Bilateral infiltrates 
31 I:128 
7 1:32 
120 
100 
125 
15.8 
8.7 
24. I Bilateral infiltrates 
Il.0 
14.0 
Bilateral infiltrate5 
Bilateral infiltrates 
Bilateral infiltrates 
Bilateral infiltrates 
erythrocytes using the Optilyse (Becton Dickinson) pro- 
cedure and subsequently incubated with the same fluor- 
escent antibodies as described above for the BAL cells. 
Lymphocytes were gated by their light scatter characteris- 
tics and measured for CD3’/CD4’ and CD3’iCDS’ cells. 
Results are expressed as percentage of total lymphocytes. 
STATISTICS 
Clinical characteristics, pulmonary function data and BAL 
cell data are presented as a median and 25th and 15th 
percentiles. Values for the BAL cell differential are pre- 
sented as a percentage of total BAL cells and values for 
lymphocyte subsets as a percentage of total lymphocytes. 
Differences in the composition of T-cell subsets in BAL and 
the blood were tested for statistical significance using the 
Wilcoxon test for paired data. 
Results 
HIGH PULMONARY DISEASE ACTIVITY 
The eight patients in the high pulmonary disease activity 
group also had highly active extrapulmonary disease, 
prominent constitutional symptoms and markedly 
elevated acute phase reactants. The median ESR was 
110 (90-120) mm h- ‘, the C-reactive protein 14.9 
(8,7-24,l) mg dl-’ and the median ANCA titre 1:96 
(1:31-l :256). Sinusitis and glomerulonephritis were more 
common than eye: heart, central nervous system, peripheral 
nervous system, skin or joint involvement, resulting in a 
median DE1 score of 8 (indicative of current involvement of 
four organ systems) (Table 1). Microbiological studies of 
blood, BAL fluid and tracheobronchial secretions were 
invariably negative and rapid clinical and radiological 
improvement in response to high-dose prednisolone sup- 
ported the assessment that the lung disease resulted from 
the underlying vasculitis and not from infection. Further- 
more, no patient had haemoptysis and in no case was 
haemorrhagic fluid recovered by BAL, which by all 
standards ruled out diffuse alveolar haemorrhage. The 
consistent BAL abnormality in these patients was an eleva- 
tion of neutrophils to values between 6 and 61% of total 
BAL cells (Fig. 1). In four patients a borderline elevation of 
the eosinophils (l-3%) was also seen, but only one patient 
had a marginally elevated lymphocyte count. 
LOW PULMONARY DISEASE ACTIVITY 
The 37 patients in the low pulmonary disease activity group 
had a median DE1 score of 4 (&6), a median erythrocyte 
sedimentation rate of 32 (18-71) mm h-l, a C-reactive 
protein of 0.5 (0.4-1.8) mg dl - 1 and an ANCA titer of 1:64 
(O-l: 128) which reflected moderate systemic disease 
activity (Table 2). Twenty-five patients had concurrent 
disease activity in the upper respiratory tract, 12 had urine 
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FIG. 1. BAL cell profile in Wegener’s granulomatosis (WG) and pulmonary sarcoidosis (SARC). Shaded areas represent 
the normal range. 
abnormalities suggestive of glomerulonephritis, 10 had ous disease and one cutaneous vasculitis. Pulmonary com- 
peripheral neuropathy, six had ophthalmic disease, six plaints were non-productive cough in 16 patients and 
arthralgia or arthritis, two heart disease, one central nerv- exertional dyspnoea in seven patients. Nine patients had a 
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TABLE 2. Characteristics of patients with low pulmonary 
disease activity due to Wegener’s granulomatosis 
Women/men (n) 
Age (years) 
Duration of disease (months) 
ESR (mm h-i) 
C-reactive protein (mg dl - ‘) 
ANCA titre (reciprocal) 
Disease extent index 
Extrapulmonary organ involvement (n) 
Ear, nose, throat 
Kidney 
Peripheral nervous system 
Eye 
Arthralgialarthritis 
Heart 
Central nervous system 
Skin 
VCIN (% of predicted) 
FEV,/ VCIN (%) 
TLCOcI VA (% of predicted) 
Arterial PO, (mmHg) 
Arterial PCO, (mmHG) 
17120 
62 (49-67) 
18 (7-75) 
32 (18-71) 
0.5 (0.4-18) 
64 (O-128) 
4 (4-6) 
25 
12 
10 
6 
6 
2 
1 
1 
100 (86-107) 
74 (64-82) 
99 (85-l 10) 
89 (81-98) 
36 (34-38) 
ANCA: anti-neutrophil cytoplasmic antibodies; VCIN: 
inspiratory vital capacity; FEV,: forced expiratory volume 
in 1 set; 7XOcIVA: transfer factor for CO corrected for 
haemoglobin and alveolar volume. 
low-grade restrictive ventilatory defect or impaired CO 
diffusion capacity but the medians for these parameters 
were within the normal range. The most prevalent HRCT 
abnormalities were small nodules, occurring singly or 
multiply, which were seen in 22 patients [Fig. 2(a)]. Septal 
or non-septal lines were seen in 20 patients [Fig. 2(a)]. They 
were focal in distribution and in no case was an extended 
reticular or honeycombing pattern seen. Focal low- 
attenuation (ground-glass) opacities were seen in seven 
patients [Fig. 2(b)]. Twenty-six of these patients had an 
abnormal BAL cell profile (Fig. 1). The most common 
abnormality, found in 25 patients, was an elevation of the 
lymphocytes to a median of 40% (2147%) of the total BAL 
cells. These patients also had an elevated total cell count in 
BAL (193 x lo3 cells ml- ‘) which also resulted in an 
elevated absolute lymphocyte count. Two patients had 
low-grade elevation of the BAL neutrophils and two 
patients had low-grade elevation of the eosinophils. 
IMMUNOTYPING OF BAL AND BLOOD 
LYMPHOCYTES 
Immunotyping was performed in the 25 low disease activity 
patients with a lymphocytic BAL profile. A median of 92% 
(85-94%) of the BAL lymphocytes were CD3’ T cells 
compared with 75% (68-82%) in the blood (Fig. 3, Table 3). 
In the BAL a median 69% of (58-78%) lymphocytes were 
CD4+ and 19% (ll-29%) were CD8+; corresponding 
values in the blood were 44% (33-50%) CD4’ cells and 3 1% 
FIG. 2. High-resolution computed tomography in 
Wegener’s granulomatosis with low pulmonary disease 
activity. (a) Subcarinal section showing septal and non- 
septal lines, a nodular lesion and pleural irregularities. 
(b) Subcarinal section showing focal low-attenuation 
opacities in the upper lobes. 
(21-340/b) CDS+ cells. This resulted in a CD4/CD8 ratio of 
4.1 (2.0-5.8) in BAL, which was significantly higher than 
the ratio of 1.4 (1.1-2.1) in the blood (P<O.OOl). The WG 
patients had the compartmentalized elevation of the CD4+ 
cells in the lung in common with the sarcoidosis patients 
(Table 3). In the latter patients 82% (65-89%) of the BAL 
lymphocytes were CD4+ and 7% (6-18%) were CD&+. 
Corresponding values in the blood were 45% (42-57%) 
CD4’ cells and 20% (18-28) CD8’ cells; the CD4/CD8 
ratios were 12.6 (5.0-15.3) in BAL and 2.2 (1.5-2.3) in 
blood (P=O.O03). 
HISTOPATHOLOGY 
TBB in the 37 patients in the low pulmonary disease activity 
group gave adequate material in 32 patients. The most 
common findings were mononuclear cell infiltrates of low 
or moderate density mainly consisting of lymphoid cells, 
while histiocytes were less common, Neutrophils and 
eosinophils were seen only occasionally (Table 4). Only five 
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FIG. 3. T cells and T-cell subsets in BAL in Wegener’s granulomatosis (WG) and pulmonary sarcoidosis (SARC) Shaded 
areas represent the normal range. 
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TABLE 3. Lymphocyte subsets in Wegener’s granulomatosis with elevated BAL lymphocytes and in 
pulmonary sarcoidosis. Values represent percentage of the total BAL lymphocytes 
BAL Blood BAL vs blood 
Wegener’s granulomatosis (n =25) 
CD3’ 
CD4’ 
CD8+ 
CD4/CD8 
Sarcoidosis (n = 11) 
CD3 + 
CD4’ 
CD8’ 
CD41CD8 
92 (85-94) 
69 (58-78) 
19 (11-29) 
4.1 (2.0-5.8) 
95 (82-96) 
82 (65-89) 
7 (6-18) 
12.6 (5.0-15.3) 
75 (68-82) 
44 (33-50) 
31 (21-34) 
I.4 (1.1-2.1) 
72 (66-78) 
45 (42-57) 
20 (18-28) 
2.2 (1.5-2.3) 
P<O.OOl 
P<O.OOl 
P=O.O14 
P<O.OOl 
P=O.O04 
P=O.O03 
P=O.O05 
P=O.O03 
patients had granulomatous lesions and three patients had 
scattered giant cells. 
Discussion 
This study demonstrates that pulmonary disease due to 
WG can be associated with two disparate BAL cell 
patterns. Patients with high pulmonary disease activity, 
characterized by extensive infiltrates in the CXR in the 
presence of high systemic disease activity, invariably had 
elevated BAL neutrophils, whereas patients with low pul- 
monary disease activity and mainly interstitial or nodular 
changes in the HRCT had elevated BAL lymphocytes or a 
normal cell profile. The lymphocytic BAL cell profile in the 
latter condition correlated with tissue infiltration by mainly 
mononuclear cells and a granulomatous histopathology. 
Immunotyping of the lymphocytes in these patients dis- 
closed a preferential elevation of the CD4’ cells in BAL 
which was not reflected in the blood. 
The finding of a neutrophilic BAL cell pattern in patients 
with high pulmonary disease activity agrees with a previous 
study which reported this finding in six WC patients with 
highly active multi-system disease (10). In another study of 
14 WG patients, a predominantly granulocytic pattern was 
found in association with high disease activity, while the 
proportion of neutrophils and lymphocytes were variable in 
the patients with moderate disease activity (11). In a 
TABLE 4. Inflammatory cells in transbronchial biopsies in 
low pulmonary disease activity due to WG (n=33). Num- 
bers of patients showing tissue infiltration with specific cell 
types are shown 
Mononuclear cells 
Lymphoid cells 
Histiocytes 
Scattered giant cells 
Granuloma 
Granulocytes 
No inflammatory cells 
27 (82%) 
25 (76%) 
20 (61%) 
3 (9%) 
5 (15%) 
3 (9%) 
5 (15%) 
nationwide collection of WG patients in France, granulo- 
cyte elevation in BAL also prevailed over lymphocyte 
elevation but these results were not formally related to 
clinical or roentgenological findings (2). Of these three 
studies only that of Barth et al. (11) included a sizable 
proportion of patients with elevated BAL lymphocytes and 
these patients had mainly moderate to severe disease. 
To substantiate the impression that a lymphocytic BAL 
cell pattern is a reflection of low or moderate pulmonary 
disease activity, we recruited a group of patients character- 
ized by a normal CXR but with HRCT findings indicating 
low-grade, mainly interstitial disease due to WG (7-9). 
HRCT abnormalities included small nodules, septal and 
non-septal lines and focal low-attenuation opacities. Pul- 
monary function was generally normal in these patients; 
only a minority had marginally depressed values for vital 
capacity and CO diffusion capacity. TBB confirmed the 
presence of low-grade inflammatory infiltration in the 
majority of these patients. In contrast to the findings in high 
pulmonary disease activity, the most common BAL abnor- 
mality in low disease activity was an elevated lymphocyte 
count. 
The existence of disparate BAL patterns in WG becomes 
plausible when these patterns are related to the documented 
histopathology of this disorder. In highly active or ‘fulmi- 
nant’ lesions the infiltrate is dominated by neutrophils 
which pervade the alveolar septa and accumulate in the 
alveoli (4,6). Infiltration mainly by neutrophils is also seen 
in the capillaritis underlying diffuse alveolar haemorrhage, 
which is a particularly severe form of pulmonary vasculitis 
(6,19). In contrast, mononuclear cells generally dominate 
the tissue infiltrate of subacute WG (4-6). Both the char- 
acteristic necrotizing granuloma and the septal infiltrate in 
the surroundings of granulomas are composed mainly of 
histiocytes and lymphocytic cells, with a variable admixture 
of multinucleate giant cells but few neutrophils (5,6,20). 
The latter features were also found in the low pul- 
monary disease activity group in this study. Obviously the 
lymphocytic BAL pattern in these patients reflects the 
predominance of mononuclear cells in the tissue. 
The preferential elevation of CD4’ cells in WG patients 
with a lymphocytic BAL cell profile is as yet unreported. 
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Immunohistological studies of the composition of the lym- 
phocytic infiltrate in respiratory tract lesions in WG appear 
to be limited to a case report and a series of upper 
respiratory tract biopsies. An open lung biopsy specimen 
from a WG patient showed infiltration by lymphocytes and 
giant cells (21). The lymphocytes were mainly CD3’ T cells, 
with a slight preponderance of CD4’ over CD8+ cells. 
Rasmussen et al. found a mixed infiltrate consisting of 
macrophages, lymphocytes and granulocytes in upper res- 
piratory tract biopsies from seven WG patients (22). The 
lymphocytes were mainly CD2’ and CD3’ T cells, with 
CD4+ cells exceeding CD8+ cells in five of the seven cases. 
These few data leave it unclear whether the unbalanced 
CD4’ cell elevation in BAL reflects the distribution of the 
T-cell subsets in the tissue. Unfortunately, the present study 
does not resolve this question as the number of lymphocytes 
in the TBB specimens of these patients was too low to allow 
a meaningful assessment of T-cell subsets. 
The preferential elevation of the CD4’ cells in BAL in 
the presence of a normal CD41CD8 ratio in the blood 
appears to be a common feature of WG patients with 
low-grade pulmonary disease and patients with pulmonary 
sarcoidosis (23). In sarcoidosis, which is also a chronic 
inflammatory disease with a proclivity for lung involve- 
ment, the pulmonary CD4+ cells are thought to be inti- 
mately involved in the pathogenesis of the granulomatous 
disease by receiving stimulatory signals from activated 
macrophages and by secreting a THl pattern of cytokines, 
which enhances the activational state of the macrophages 
(24,25). A recent study of blood cells suggested that a 
disordered interaction between T cells and circulating 
monocytes is also involved in WG and that this includes 
secretion of a THl type pattern of cytokines from activated 
CD4’ but not CD8’ cells (26). In addition to these 
findings, one might speculate that the expanded pulmonary 
CD4’ cell component plays a similar role in WG as in 
sarcoidosis, but this needs to be substantiated by functional 
studies. 
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